Mikyung Yu

2.7k total citations
19 papers, 2.0k citations indexed

About

Mikyung Yu is a scholar working on Molecular Biology, Biomaterials and Surgery. According to data from OpenAlex, Mikyung Yu has authored 19 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Biomaterials and 2 papers in Surgery. Recurrent topics in Mikyung Yu's work include RNA Interference and Gene Delivery (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Mikyung Yu is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Mikyung Yu collaborates with scholars based in United States, Saudi Arabia and South Korea. Mikyung Yu's co-authors include Omid C. Farokhzad, Jinjun Shi, Jun Wu, Wei Tao, Xiaoding Xu, Morteza Mahmoudi, Yanlan Liu, Phei Er Saw, Harshal Zope and Róbert Langer and has published in prestigious journals such as Angewandte Chemie International Edition, Nano Letters and ACS Nano.

In The Last Decade

Mikyung Yu

19 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikyung Yu United States 14 1.1k 747 711 295 236 19 2.0k
Ji Young Yhee South Korea 29 1.2k 1.1× 808 1.1× 851 1.2× 129 0.4× 220 0.9× 63 2.5k
Junchao Xu China 23 1.0k 1.0× 617 0.8× 1.1k 1.6× 296 1.0× 392 1.7× 38 2.4k
Hanqing Qian China 25 689 0.6× 752 1.0× 725 1.0× 220 0.7× 249 1.1× 58 1.8k
Zhiting Cao China 21 1.1k 1.0× 823 1.1× 887 1.2× 236 0.8× 235 1.0× 27 2.1k
Qingsong Yu China 22 583 0.5× 787 1.1× 933 1.3× 126 0.4× 259 1.1× 57 1.7k
Ayuob Aghanejad Iran 36 866 0.8× 934 1.3× 1.2k 1.7× 187 0.6× 317 1.3× 81 2.7k
Amir K. Varkouhi Netherlands 12 1.4k 1.3× 592 0.8× 498 0.7× 175 0.6× 193 0.8× 17 2.0k
Nuria Oliva United Kingdom 14 670 0.6× 688 0.9× 821 1.2× 116 0.4× 210 0.9× 21 1.7k
Yeh‐Hsing Lao United States 27 1.7k 1.6× 584 0.8× 1.1k 1.5× 309 1.0× 429 1.8× 59 2.8k
Yingjuan Lu United States 18 876 0.8× 622 0.8× 509 0.7× 198 0.7× 213 0.9× 34 1.8k

Countries citing papers authored by Mikyung Yu

Since Specialization
Citations

This map shows the geographic impact of Mikyung Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikyung Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikyung Yu more than expected).

Fields of papers citing papers by Mikyung Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikyung Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikyung Yu. The network helps show where Mikyung Yu may publish in the future.

Co-authorship network of co-authors of Mikyung Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Mikyung Yu. A scholar is included among the top collaborators of Mikyung Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikyung Yu. Mikyung Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bailey, Keith, et al.. (2025). Treatment of Acute Liver Injury through Selective Tropism of High Mobility Group Box 1 Gene-Silenced Large Peritoneal Macrophages. ACS Nano. 19(12). 12102–12118. 2 indexed citations
2.
3.
Dadali, Tulin, Stephen B.G. Abbott, Mikyung Yu, et al.. (2024). Abstract 5924: RNAi mediated inhibition of beta-catenin demonstrates anti-tumor efficacy and immune microenvironment modulation in preclinical hepatocellular carcinoma models. Cancer Research. 84(6_Supplement). 5924–5924. 1 indexed citations
4.
Molinaro, Roberto, Mikyung Yu, Grasiele Sausen, et al.. (2021). Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity. Cardiovascular Research. 117(13). 2652–2663. 71 indexed citations
5.
Ling, Xiang, Jiasheng Tu, Junqing Wang, et al.. (2018). Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy. ACS Nano. 13(1). 357–370. 227 indexed citations
6.
Yu, Mikyung, Roberto Molinaro, Frederick J. Schoen, et al.. (2018). Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery. Theranostics. 8(21). 6008–6024. 20 indexed citations
7.
Islam, Mohammad Ariful, Yingjie Xu, Wei Tao, et al.. (2018). Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nature Biomedical Engineering. 2(11). 850–864. 263 indexed citations
8.
Xu, Xiaoding, Phei Er Saw, Wei Tao, et al.. (2017). Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy. Nano Letters. 17(7). 4427–4435. 115 indexed citations
9.
Xu, Xiaoding, Jun Wu, Yanlan Liu, et al.. (2017). Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy. ACS Nano. 11(3). 2618–2627. 181 indexed citations
10.
Mahmoudi, Morteza, Mikyung Yu, Vahid Serpooshan, et al.. (2017). Multiscale technologies for treatment of ischemic cardiomyopathy. Nature Nanotechnology. 12(9). 845–855. 106 indexed citations
11.
Saw, Phei Er, et al.. (2017). Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy. Biomaterials. 123. 118–126. 37 indexed citations
12.
Yu, Mikyung, Renata Ferreira de Carvalho Leitão, Xiaoding Xu, et al.. (2017). Abstract 467: Fibronectin Extradomain B (FN-EDB) Expression is Specific to the Atherosclerotic Lesion Types III, IV, and V, and the FN-EDB targeting Nanomedicine Enhances Atherosclerotic Plaque Detection and Local Delivery of Model Drug Cargo. Arteriosclerosis Thrombosis and Vascular Biology. 37(suppl_1). 1 indexed citations
13.
Yu, Mikyung, Jaume Amengual, Nazila Kamaly, et al.. (2017). Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr−/− Mice. Advanced Healthcare Materials. 6(20). 69 indexed citations
14.
Xu, Xiaoding, Jun Wu, Yanlan Liu, et al.. (2016). Ultra‐pH‐Responsive and Tumor‐Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti‐Cancer Efficacy. Angewandte Chemie. 128(25). 7207–7210. 13 indexed citations
15.
Kamaly, Nazila, Gabrielle Fredman, Manikandan Subramanian, et al.. (2016). Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis. ACS Nano. 10(5). 5280–5292. 176 indexed citations
16.
Xu, Xiaoding, Jun Wu, Yanlan Liu, et al.. (2016). Ultra‐pH‐Responsive and Tumor‐Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti‐Cancer Efficacy. Angewandte Chemie International Edition. 55(25). 7091–7094. 224 indexed citations
17.
Yu, Mikyung, Jun Wu, Jinjun Shi, & Omid C. Farokhzad. (2015). Nanotechnology for protein delivery: Overview and perspectives. Journal of Controlled Release. 240. 24–37. 319 indexed citations
18.
Choi, Won Il, Nazila Kamaly, Lorena Riol‐Blanco, et al.. (2014). A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins. Nano Letters. 14(11). 6449–6455. 37 indexed citations
19.
Park, Kyeongsoon, Yoo-Shin Kim, Mikyung Yu, et al.. (2006). Heparin–deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity. Journal of Controlled Release. 114(3). 300–306. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ji Young Yhee Breakdown of academic impact, for papers by Junchao Xu Breakdown of academic impact, for papers by Hanqing Qian Breakdown of academic impact, for papers by Zhiting Cao Breakdown of academic impact, for papers by Qingsong Yu Breakdown of academic impact, for papers by Ayuob Aghanejad Breakdown of academic impact, for papers by Amir K. Varkouhi Breakdown of academic impact, for papers by Nuria Oliva Breakdown of academic impact, for papers by Yeh‐Hsing Lao Breakdown of academic impact, for papers by Yingjuan Lu
Rankless by CCL
2026